GlaxoSmithKline (NYSE: GSK) announced that data from a three-year study of patients with Chronic Obstructive Pulmonary Disease (COPD) found that the inhaled corticosteroid in Advair Diskus 250/50, fluticasone propionate, did not show an adverse effect on bone mineral density (BMD) measured at the lumbar spine and total hip compared to salmeterol alone.

Trust for America’s Health (TFAH) released a new report, Germs Go Global: Why Emerging Infectious Diseases Are a Threat to America; which finds that at least 170,000 Americans die annually from newly emerging and re-emerging infectious diseases, a number that could increase dramatically during a severe flu pandemic or yet-unknown disease outbreak.

Research shows that proprietary non-brain penetrant cannabinoid subtype 1 (CB1) receptor antagonists developed by Jenrin Discovery are able to produce metabolically favorable effects in peripheral tissues, including fat and liver.

With suicide the second-leading cause of death for Wyoming youths ages 15-19, the Wyoming Department of Health is beginning a new program with public and private partners to help address the role of schools in youth suicide prevention.

Women who experience severe gestational hypertension may give birth to boys at lower risk for testicular cancer, although the exact reasons why are still unclear, according to a paper published in the November 1, 2008, issue of Cancer Research a journal of the American Association for Cancer Research. Andreas Pettersson, M.D.

An innovative project that lets heart patients undertake supervised exercise at home using a mobile phone, miniature heart monitor and GPS device, has been recognised in a prestigious international competition. The “Cardiomobile” system, developed by scientists and engineers at Queensland University of Technology and Gold Coast-based company Alive Technologies, was the winner of the inaugural Australian leg of the fifth European Satellite Navigation Competition, this year.

An international trial found that the new drug tociluzumab, when given in combination with methotrexate, was fast, effective and reasonably tolerated compared to placebo in treating patients with rheumatoid arthritis that had not responded to TNF therapy.

Onconova Therapeutics, Inc. announced today the publication of positive results from a first-in-human Phase I clinical trial of its lead anticancer drug, ON 01910.Na, in advanced refractory solid tumors. The publication will be online today in the Journal of Clinical Oncology and will appear in a future print edition of the journal. A first-in-class targeted therapy, ON 01910.

Offering another reason why eating red meat could be bad for you, an international research team, including University of California, San Diego School of Medicine professor Ajit Varki, M.D., has uncovered the first example of a bacterium that causes food poisoning in humans when it targets a non-human molecule absorbed into the body through red meats such as lamb, pork and beef.

Bayhill Therapeutics, Inc., a leading developer of therapies for autoimmune diseases, and the Juvenile Diabetes Research Foundation, the world’s leading charitable funder of type 1 diabetes research, today announced a partnership to support Bayhill’s ongoing Phase I/II human clinical trial of BHT-3021, a DNA vaccine to reverse the immune response that causes type 1 diabetes.